Summary
The first-in-human trial of a miniaturized leadless transcatheter pacing system finds a rate of serious adverse events in line with traditional transvenous pacing systems and as-expected electrical performance, offering a promising solution to permanent pacing.
- transvenous pacing
- bradycardia
- miniaturized leadless pacing system
- sinus node dysfunction
- atrioventricular block
- Mitra Transcatheter Pacing study
- NCT02004873
- first in human
- arrhythmias
- cardiology & cardiovascular medicine clinical trials
- interventional techniques & devices
- © 2015 SAGE Publications